INDOAMIN Stock Overview
Engages in the manufacture, distribution, and sale of fine and specialty chemicals in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 5/6 |
My Notes
Capture your thoughts, links and company narrative
Indo Amines Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹142.74 |
| 52 Week High | ₹248.40 |
| 52 Week Low | ₹106.60 |
| Beta | 0.90 |
| 1 Month Change | -15.86% |
| 3 Month Change | -18.09% |
| 1 Year Change | -17.61% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 25.93% |
Recent News & Updates
Is Indo Amines (NSE:INDOAMIN) Using Too Much Debt?
Jan 29
Investors Don't See Light At End Of Indo Amines Limited's (NSE:INDOAMIN) Tunnel And Push Stock Down 26%
Jan 14Indo Amines (NSE:INDOAMIN) Will Be Hoping To Turn Its Returns On Capital Around
Dec 05Recent updates
Is Indo Amines (NSE:INDOAMIN) Using Too Much Debt?
Jan 29Investors Don't See Light At End Of Indo Amines Limited's (NSE:INDOAMIN) Tunnel And Push Stock Down 26%
Jan 14Indo Amines (NSE:INDOAMIN) Will Be Hoping To Turn Its Returns On Capital Around
Dec 05There's Reason For Concern Over Indo Amines Limited's (NSE:INDOAMIN) Massive 32% Price Jump
Sep 26Indo Amines (NSE:INDOAMIN) Is Due To Pay A Dividend Of ₹0.50
Sep 17Indo Amines (NSE:INDOAMIN) Is Paying Out A Dividend Of ₹0.50
Sep 03Indo Amines Limited (NSE:INDOAMIN) Shares Fly 30% But Investors Aren't Buying For Growth
Aug 12Indo Amines (NSE:INDOAMIN) Has Affirmed Its Dividend Of ₹0.50
Aug 11Here's Why Indo Amines (NSE:INDOAMIN) Has A Meaningful Debt Burden
Aug 07Does Indo Amines (NSE:INDOAMIN) Deserve A Spot On Your Watchlist?
Jul 17Indo Amines Limited's (NSE:INDOAMIN) Earnings Are Not Doing Enough For Some Investors
Jun 28Indo Amines Limited (NSE:INDOAMIN) Might Not Be As Mispriced As It Looks After Plunging 25%
Mar 09Does Indo Amines (NSE:INDOAMIN) Have A Healthy Balance Sheet?
Feb 18Should You Be Adding Indo Amines (NSE:INDOAMIN) To Your Watchlist Today?
Jan 31Even With A 33% Surge, Cautious Investors Are Not Rewarding Indo Amines Limited's (NSE:INDOAMIN) Performance Completely
Jan 03A Look Into Indo Amines' (NSE:INDOAMIN) Impressive Returns On Capital
Dec 07Pinning Down Indo Amines Limited's (NSE:INDOAMIN) P/E Is Difficult Right Now
Jun 14Shareholder Returns
| INDOAMIN | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | -4.6% | -0.7% | -1.4% |
| 1Y | -17.6% | 0.9% | 5.8% |
Return vs Industry: INDOAMIN underperformed the Indian Chemicals industry which returned 0.9% over the past year.
Return vs Market: INDOAMIN underperformed the Indian Market which returned 5.8% over the past year.
Price Volatility
| INDOAMIN volatility | |
|---|---|
| INDOAMIN Average Weekly Movement | 7.9% |
| Chemicals Industry Average Movement | 5.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: INDOAMIN's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: INDOAMIN's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 557 | Vijay Palkar | indoaminesltd.com |
Indo Amines Limited engages in the manufacture, distribution, and sale of fine and specialty chemicals in India and internationally. The company’s fine chemicals comprise aliphatic and aromatic amines, aliphatic and aromatic nitriles, halides, alcohols, cycloalkanols, cycloalkanones, acids and esters, advanced intermediates, amine hydrochlorides, ethanol amines, and other products. Its specialty chemicals include fatty acids, amides, amines, di-amines, tertiary amines, polyamines, amine ethoxylates, and ammonium quats.
Indo Amines Limited Fundamentals Summary
| INDOAMIN fundamental statistics | |
|---|---|
| Market cap | ₹10.06b |
| Earnings (TTM) | ₹516.10m |
| Revenue (TTM) | ₹9.81b |
19.5x
P/E Ratio1.0x
P/S RatioIs INDOAMIN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| INDOAMIN income statement (TTM) | |
|---|---|
| Revenue | ₹9.81b |
| Cost of Revenue | ₹6.72b |
| Gross Profit | ₹3.09b |
| Other Expenses | ₹2.58b |
| Earnings | ₹516.10m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.30 |
| Gross Margin | 31.51% |
| Net Profit Margin | 5.26% |
| Debt/Equity Ratio | 91.1% |
How did INDOAMIN perform over the long term?
See historical performance and comparisonDividends
0.4%
Current Dividend Yield7%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/30 23:01 |
| End of Day Share Price | 2025/01/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Indo Amines Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Anil Burra | FirstCall Research |
| Bikshapathi A. | FirstCall Research |